Differences in pharmacology and their translation into differences in clinical efficacy – a comparison of the renin angiotensin blocking agents irbesartan and losartan

Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation

(2009) X. Lan et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Chronic Treatment With Losartan Results in Sufficient Serum Levels of the Metabolite EXP3179 for PPARγ Activation

(2009) Kai Kappert et al.   HYPERTENSION

Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations?

(2009)   JOURNAL OF HYPERTENSION

Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden

(2008) M Ekman et al.   JOURNAL OF HUMAN HYPERTENSION

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effects of losartan on signal-averaged P wave in patients with atrial fibrillation

(2007) Masahiro Nomura et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure

(2007) Leo Chi-Chiu Kum et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY